ARS Pharmaceuticals, Inc. SPRY Other Nonoperating Income
Other Nonoperating Income at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncome.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s other nonoperating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s other nonoperating income?
- ARS Pharmaceuticals, Inc. (SPRY) reported other nonoperating income of $1.97M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s other nonoperating income changed year-over-year?
- ARS Pharmaceuticals, Inc.'s other nonoperating income decreased by 39.2% year-over-year, from $3.24M to $1.97M.
- What does other nonoperating income mean?
- This captures income generated from activities outside the company's core business operations, such as interest income, gains from asset sales, or foreign exchange adjustments. It provides insight into the company's ability to generate supplemental cash flow from non-core assets. Investors use this to distinguish between operational performance and peripheral financial gains.